Media-OutReach Newswire Announcing profit of almost USD 232.4 million and adopting Basel III, HDBank continues moving forward with its sustainable business plan
Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases